Atlas Trials

Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment

Clinical trial NCT06683950 · COMPLETED

Trial details

NCT number
NCT06683950
Sponsor
Kim's Eye Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Age-related Macular Degeneration (ARMD)
Start date
2024-10-21
Primary completion
2026-07-14
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.